
|Videos|June 12, 2019
Dr. Hope S. Rugo on the SOPHIA Trial in HER2+ Breast Cancer
Author(s)Hope S. Rugo, MD
Cancer Network spoke with Hope S. Rugo, MD, of the University of California, San Francisco, about the results of the phase III SOPHIA trial in HER2-positive breast cancer.
Advertisement
Cancer Network spoke with Hope S. Rugo, MD, of the University of California, San Francisco, about the results of the phase III SOPHIA trial in HER2-positive breast cancer.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab Yields High pCR Rate in Desmoplastic Melanoma
2
New ASCO Guideline Offers Recommendations for Smoldering Multiple Myeloma
3
Fecal Microbiota Transplantation Shows Feasibility in Metastatic RCC
4
Reducing Secondary Diagnostic Delay Through the Breast Clinical Reporting and Data System
5
































